I guess the highlights are:
- discussions with potential partners for trof ex-NA progressing, with strong interest received from multiple parties
- Revised Angelman syndrome protocol has been submitted to FDA, Phelan-McDermid and Pitt Hopkins protocols to be submitted shortly
Ann: Q4 2021 quarterly activity and cash flow report, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.78 |
Change
0.300(1.82%) |
Mkt cap ! $2.109B | |||
| Open | High | Low | Value | Volume |
| $16.65 | $16.90 | $16.33 | $3.666M | 218.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59 | $16.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.79 | 37 | 1 |
View Market Depth
| Last trade - 14.15pm 29/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |